An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States
Introduction The treatment with tyrosine kinase inhibitors (TKIs) has drastically improved the outcome of chronic myeloid leukemia (CML) patients. This study was conducted to examine the risk of secondary cancers (SCs) in the CML patients who were diagnosed and treated in the TKI era in the United S...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2018-02-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/4342.pdf |